| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09fa84c54c24536575f7f12c1f1db43 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-484 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
| filingDate |
1978-06-21^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1979-12-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241b4d7ae3d6a7fdef8297ef31ac4610
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbef2d4c9cdc9a1b9f6d2fcc70af4855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922b55145c9a13a4a5d29d4907aebc86 |
| publicationDate |
1979-12-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4178368-A |
| titleOfInvention |
Method for the treatment of thromboembolism |
| abstract |
A method for the treatment of thromboembolisms in a patient, said method consisting essentially of intravenously administering to said patient an effective amount of a complex formed between streptokinase and plasminogen in a mol ratio from 2:1 to 1:2 in combination with a physiologically tolerable aqueous liquid diluent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002045856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5776452-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0035204-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4305926-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0035204-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5051264-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DK-156698-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4440679-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4808405-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6699230-B2 |
| priorityDate |
1971-09-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |